Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | Summary
Summary
Glenmark Pharmaceuticals Ltd.
BSE CODE: 532296   |   ISIN CODE : INE935A01035
BSE
586.00
0.05 ( 0.01% )
 
Prev Close ( Rs.)
585.95
Open ( Rs.)
0.00
 
High ( Rs.)
0.00
Low ( Rs.)
0.00
 
Volume
0
Week Avg.Volume
104026
 
52 WK High-Low Range
BSE NSE
586.75
0 ( 0% )
 
Prev Close ( Rs.)
586.75
Open ( Rs.)
583.95
 
High ( Rs.)
603.40
Low ( Rs.)
580.50
 
Volume
3459504
Week Avg.Volume
2145942
 
52 WK High-Low Range
493.5
746
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Piramal Enterprises2559.0058.85(2.35)835.850.00
Natco Pharma839.709.70(1.17)96.520.00
Panacea Biotec278.006.30(2.32)8.390.00
Ind-Swift Lab.95.704.50(4.93)50.510.00
Biocon628.004.25(0.68)327.010.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Glenn Saldanha
Managing Director
Glenn Saldanha
Company Secretary
Harish Kuber
Executive Director
Cherylann Pinto
Non Executive Director
Rajesh V Desai
Promoter & Non-Executive Director
B E Saldanha
Registered Office :
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, , Mumbai,
Maharashtra-400026 .
Phone :
 
E-mail :
webmaster@glenmarkpharma.com
URL
www.glenmarkpharma.com
 
News On GLENMARK
07/06/2018
Glenmark moves up on receiving...
06/06/2018
Glenmark Pharmaceuticals infor...
06/06/2018
Glenmark receives USFDA's appr...
31/05/2018
Glenmark advances on getting n...
More >
Financials
QUARTERLY (Mar 18)
Net Profit( Rs . In Cr) 2215.12
Gross Profit( Rs . In Cr) 2940.69
Operating Profit( Rs . In Cr) 3746.09
Net Sales( Rs .In Cr) 16677.45
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
HDFC Mid-Cap Opportu...211.58
DSPBR Equity Opportu...59.66
SBI Magnum TaxGain'9...54.79
HDFC Capital Builder...41.69
Mirae Asset Emerging...40.00
Reliance Pharma Fund...36.85
HDFC TaxSaver(G)27.24
More>
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: NSE~ INB/F/E 231445330 | BSE~INB/F 231445330 | MSE- INB040817131 | DP~IN-DP-CDSL-683-2013 | Member ID : NSE :14453 | BSE: 6281 |MSE: 08171| MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110

NSE
×